Manufacture of pharmaceutical preparations

GENTILI PHARMA AS

Org. no. 931481177 Limited company (AS) Oslo Incorporated 2023 Active

Ownership graph ↗

Operating profit NOK −6,000

Equity NOK 56,000

Incorporated 2023

Share capital NOK 100,000

Overview Details Financials Key figures Roles and owners Organisation Announcements

Announcements

Changes recorded in the Brønnøysund registers, collected continuously from the update feed.

6 Jul 2026 Register change

Enhet endret i Enhetsregisteret
11 Jun 2026 Register change

Enhet endret i Enhetsregisteret
11 Dec 2025 Register change

Enhet endret i Enhetsregisteret
12 Nov 2025 Register change

Enhet endret i Enhetsregisteret
12 Aug 2025 Register change

Enhet endret i Enhetsregisteret
12 May 2025 Register change

Enhet endret i Enhetsregisteret
12 Apr 2025 Register change

Enhet endret i Enhetsregisteret
10 Feb 2025 Register change

Enhet endret i Enhetsregisteret
12 Dec 2024 Register change

Enhet endret i Enhetsregisteret
14 Oct 2024 Register change

Enhet endret i Enhetsregisteret
11 Sep 2024 Register change

Enhet endret i Enhetsregisteret
13 Jul 2024 Register change

Enhet endret i Enhetsregisteret
12 Jun 2024 Register change

Enhet endret i Enhetsregisteret
4 May 2024 Register change

Enhet endret i Enhetsregisteret
2 May 2024 Register change

Enhet endret i Enhetsregisteret
29 Jan 2024 Register change

Enhet endret i Enhetsregisteret
1 Jan 2024 Register change

Enhet endret i Enhetsregisteret
31 Oct 2023 Register change

Enhet endret i Enhetsregisteret
30 Oct 2023 Register change

Enhet endret i Enhetsregisteret
1 Jun 2023 New registration

Ny enhet registrert i Enhetsregisteret

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Free · complete

Get the full picture ofGENTILI PHARMA AS

Open the full company report for complete insight.

Detailed financials and key figures

Valuation and financial analysis

Roles, owners and group structure

Credit rating and payment history

Comparison and trends over time

GENTILI PHARMA AS · Rapport

Open the full report →

Secure and simple

Valuation

NOK 65,000

NOK 60,000 – NOK 71,000

Confidence: low
Method: asset_only
Norm. EBIT: NOK −6,000
Required return: 18.0%
Book equity: NOK 56,000

See the full valuation →

Ownership graph

Explore the full ownership structure and group map interactively.

Open the graph ↗